Hilpi Rautelin's 124 research works with 4,298 citations and 5,649 reads, including: Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors

2017-05-05 · ORION CORPORATION MANAGERS' TRANSACTIONS 5 MAY 2017 at 10.04 EEST Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market

hilpi.rautelin@medsci.uu.se. Department of Medical Sciences, Clinical Microbiology, Uppsala University, Hilpi Rautelin,. Hilpi Rautelin. Department of Bacteriology and Immunology, University of Helsinki and Helsinki University Central Hospital Laboratory Hilpi Rautelin' and Maria- Liisa Hanninen2. Campylobacters have been known as important human pathogens since the late 1970s. Campylobacter jejuni and Pesonen, E. , Andsberg, E. , Ohlin, H. , Puolakkainen, M. , Rautelin, H. , Sarna, S. et al. (2007) Dual role of infections as risk factors for coronary heart disease.

View all 9 activities Hilpi Rautelin Member of the Board of Directors of Orion Corporation since 22 March 2017 Chairman of the R&D Committee, member of the Personnel and Remuneration Committee Independent of the company and its significant shareholders Professor at Department of Medical Sciences, Clinical Microbiology \nHilpi.Rautelin@medsci.uu.se\n+4618-6119614 \n \n Hilpi Rautelin - Uppsala University, Sweden Skip to … Hilpi Rautelin's 124 research works with 4,298 citations and 5,649 reads, including: Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors Publications (10 of 33) Show all publications Sarhadi, V., Lahti, L., Saberi, F., Youssef, O., Kokkola, A., Karla, T., . . . Knuutila, S. (2020).

Hygienläkare Daniel Heimer från Västerås delgav oss sina erfarenheter från utbrotten där. Professor Hilpi Rautelin berättade om situationen i Finland vad gäller.

08.00-16.30, lunch 12-13 Expedition 018-611 39 16. E-post: expeditionen.kmb@akademiska.se Läkare mikrobiolog för bakteriologiska frågor. Måndag-fredag 9-16.30 Hilpi Rautelin Orion Oyj:n hallituksen jäsen alkaen 22.3.2017 Tutkimusvaliokunnan puheenjohtaja, henkilöstö- ja palkitsemisvaliokunnan jäsen Riippumaton yhtiöstä ja sen merkittävistä osakkeenomistajista Serologic diagnosis of campylobacter infections by enzyme immunoassay / Hilpi Rautelin Rautelin, Hilpi (författare) ISBN 951-99871-2-6 Helsinki, 1987 Engelska 113 s.

Rautelin, Hilpi ORCID iD icon Emerging Infectious Diseases, 25(3), 515-522Johansson, C., Rautelin, H. & Kaden, R. (2019). Staphylococcus argenteus and

Rautelin, Hilpi Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Microbiology. (English) In: Article in journal (Other academic) Submitted Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis Rautelin, Hilpi, 1961- (author) Uppsala universitet,Klinisk bakteriologi Selected publications Hilpi Rautelin Kampmann C, Dicksved J, Engstrand L, Rautelin H. Composition of human feacal microbiota in resistance to Campylobacter infection. Clin Microbiol Infect 2016; 22: 61.e1-.e8 Rautelin Hilpi. Sweden (full member) hilpi.rautelin@medsci.uu.se. Kumlin Urban. Sweden (full member) urban.kumlin@regionvasterbotten.se: Zbinden Reinhard. Switzerland (full member) rzbinden@imm.uzh.ch.

Swedish Research Council; AcademiaNet member since 25.06.2014; AcademiaNet- Selection Criteria Employed by Hilpi Rautelin's 124 research works with 4,298 citations and 5,649 reads, including: Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors Hilpi Rautelin professor vid Institutionen för medicinska vetenskaper, Klinisk Mikrobiologi. E-post: Hilpi.Rautelin [AT-tecken] medsci.uu.se Telefon: 018-611 9614. Orion Corporation: Managers’ transactions – Hilpi Rautelin. Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Hilpi Rautelin is Professor at University of Uppsala.
Vad menas med defensiv körning

Switzerland (full member) dieter.burki@breitband.ch. Sayiner Arzu. Turkey (associate member) arzu.sayiner@deu.edu.tr. Sener Burcin ORION CORPORATION MANAGERS’ TRANSACTIONS 12th June 2020 at 17.00 EEST Orion Corporation: Managers’ transactions – Hilpi RautelinOrion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Person subject to the Elevated infection parameters and infection symptoms predict an acute coronary event. / Pesonen, Erkki; Andsberg, Eva; Grubb, Anders; Rautelin, Hilpi; Meri, Seppo 2019-02-20 · (2)Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden hilpi.rautelin@medsci.uu.se.

11.00-12.00.
Duvning betydelse

ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MARCH 2021 at 11.00 EET Orion Corporation: Managers’ transactions – Jukka Ylppö Orion

N2 - Because Helicobacter pylori persist for decades in the human stomach, the aim of this study was to examine the long-term course of H. pylori-specific serum immunoglobulin G (IgG) responses with respect to subclass and antigenic target. Electronic address: hilpi.rautelin@medsci.uu.se. 2 Department of Medical Sciences, Clinical Microbiology, Uppsala University, Uppsala, Sweden; Department of Animal Nutrition and Management, Swedish University of Agricultural Sciences, Uppsala, Sweden. ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MARCH 2021 at 11.00 EET Orion Corporation: Managers’ transactions – Jukka Ylppö Orion Rautelin H 2013 . Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response .